HealthQuill Health
Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from China’s Jiangsu Hengrui Pharmaceuticals Co., Ltd. in a $2 billion deal.
Drugs Health Pharma

Merck signs $2b licensing deal with Jiangsu Hengrui for heart disease drug

HQ Team March 25, 2025: Merck & Co., Inc. has bought global rights for an experimental oral drug to treat heart diseases from.

Read More
A diet rich in plant-based foods during midlife, with a lower intake of ultra-processed and moderate animal-based foods can help you to reach the age of 70, free from chronic diseases, a Harvard study reveals.
Drugs Health Research

Plant-based foods may help you live without chronic diseases until 70

HQ Team March 25, 2025: A diet rich in plant-based foods during midlife, with a lower intake of ultra-processed and moderate animal-based foods.

Read More
Progress in slowing child mortality and stillbirth deaths has received a severe blow due to funding cuts and shortages, with 1.9 million children dying in 2023 on account of stillbirths.
Drugs Health Pharma

Funding cuts ‘severely’ bleeding UN’s child survival, stillbirth programs

HQ Team March 25, 2025: Progress in slowing child mortality and stillbirth deaths has received a severe blow due to global funding cuts.

Read More
Obesity is a health risk that needs to be tackled worldwide
Health Medical

Weight loss offers health benefits, even if pounds creep back: Study

Bharti Jayshankar March 24, 2025: University of Gothenburg researchers have uncovered a silver lining for those who struggle to maintain weight loss. According.

Read More
depression
Health Research

Research exposes dangers of viral claims in TikTok’s ADHD postings

HQ Team March 22, 2025: Social media misinformation, especially regarding mental health issues, is a rising problem. Platforms like YouTube and TikTok attract.

Read More
US adults who will develop dementia every year will rise to one million in 2060 from 514,000 in 2020, according to a study published in Nature Medicine.
Health

Semaglutide may combat Alzheimer’s by reducing brain inflammation:Study

HQ Team March 21, 2025: A study from China adds to mounting evidence that semaglutide—a medication widely used for type 2 diabetes (Ozempic).

Read More
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Health Research

Scientists unveil PINK1 protein structure, paving way for Parkinson’s Disease therapies

HQ Team March 20, 2025: Scientists at the Walter and Eliza Hall Institute (WEHI, Australia) have uncovered the structure of the PINK1 protein.

Read More
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Health Research

Key protein ArfGAP2 identified as driver of autoimmune diseases

HQ Team March 20, 2025: Researchers have identified a protein, ArfGAP2, that triggers harmful immune responses in autoimmune diseases, offering a novel target.

Read More
The UNICEF and the private-public partnership Gavi Vaccine Alliance will roll out its malaria vaccine for the first time in nine African countries to fight one of the deadliest diseases in the continent, according to the WHO.
Drugs Health

Abrupt cessation of US funds could lead to 3 million HIV-related deaths: WHO

HQ Times March 18, 2025: The strides made in disease containment and eradication such as malaria, HIV, and tuberculosis in the last 20.

Read More
Grey matter in the human brain may be linked to the start of adolescent smoking and nicotine addiction — a study that may have implications for prevention and treatment.
Health Research

MIT’s 40Hz gamma stimulation shows promise in slowing Alzheimer’s progression

HQ Team March 15, 2025: A decade of research at MIT’s Picower Institute for Learning and Memory has brought hope to millions battling.

Read More